BioCentury
ARTICLE | Politics & Policy

NCI’s Sharpless to become acting FDA commissioner

March 12, 2019 4:49 PM UTC

Ned Sharpless, director of the National Cancer Institute, will serve as acting FDA commissioner when Scott Gottlieb leaves the agency in mid-April. Speaking at a congressional hearing Tuesday, HHS Secretary Alex Azar announced that Douglas Lowy will serve as acting NCI director while Sharpless is acting FDA commissioner.

“The process of searching for a permanent commissioner of Food and Drugs is underway,” an HHS spokesperson said...